Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
October 16 2019 - 6:02AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
FORM
15
CERTIFICATION
AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION
12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF
DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934.
Commission
File Number: 000-52445
PETLIFE
PHARMACEUTICALS, INC.
(Exact
name of registrant as specified in its charter)
8033
Sunset Blvd, Suite 867
Los
Angeles, CA 90046
(424)
216-6807
(Address,
including zip code and telephone number, including area code, of
registrant’s
principal executive offices)
Common
Stock, $0.001 par value
(Title
of each class of securities covered by this Form)
None
(Titles
of all other classes of securities for which a duty to file reports
under
section 13(a) or 15(d) remains)
Please
place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file
reports:
|
Rule
12g-4(a)(1)
|
|
[X]
|
|
|
Rule
12g-4(a)(2)
|
|
[ ]
|
|
|
Rule
12h-3(b)(1)(i)
|
|
[ ]
|
|
|
Rule
12h-3(b)(1)(ii)
|
|
[ ]
|
|
|
Rule
15d-6
|
|
[ ]
|
|
|
Rule
15d-22(b)
|
|
[ ]
|
|
Approximate
number of holders of record as of the certification or notice date: 210
Pursuant
to the requirements of the Securities Exchange Act of 1934, Petlife Pharmaceuticals, Inc. has duly caused this certification/notice
to be signed on its behalf by the undersigned duly authorized person.
|
|
Petlife Pharmaceuticals, Inc.
|
|
|
|
|
|
Date: October 15, 2019
|
By:
|
/s/
Sebastian Serrell-Watts
|
|
|
|
Sebastian Serrell-Watts, CEO
|
Petlife Pharmaceuticals (CE) (USOTC:PTLF)
Historical Stock Chart
From Mar 2024 to Apr 2024
Petlife Pharmaceuticals (CE) (USOTC:PTLF)
Historical Stock Chart
From Apr 2023 to Apr 2024
